Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/25/11 → 6/30/12 |
MACSI Study: Protocol 01373: A Double-Blind, Randomized, Placebo-Controlled, Parllel Group, Multi-Center Phase 3 Pivotal Study to Assess the Safety and Efficacy of 1mg/day Intravenous DP-b99 Over Four Consecutive Days
- Pettigrew, Luther (PI)